| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 06/28/2006 | CN1793137A Process for semi-synthesizing of apiolin |
| 06/28/2006 | CN1793136A Process for producing kuh-seng total flavone and flavone salt |
| 06/28/2006 | CN1793135A Process for producing kuh-seng total flavone and flavone salt by kuh-seng |
| 06/28/2006 | CN1793134A Process for separating purifying actived tea polyphenols |
| 06/28/2006 | CN1261586C Method for preparing aglycon of soybean isoflavone glycoside base by enzymatic method hydrolyzing soybean |
| 06/28/2006 | CN1261585C Method for preparing isoquercetin and quercetin by enzymatic method and hydrolyzing rutin |
| 06/28/2006 | CN1261431C 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 06/28/2006 | CN1261426C Iodobenzopyrran-4-one derivatives having fungicidal activity |
| 06/28/2006 | CN1261425C Process for extracting water grind thisvine using alcohole as single organic dissolvent |
| 06/28/2006 | CN1261424C Extraction and refining process of medicinal components in migao |
| 06/27/2006 | US7067679 Therapy for breast cancer; plant extracts |
| 06/27/2006 | US7067678 deprotonation of nepetalactone and treatment with Grignard reagent to form 3-alkyl and -aryl substituted compounds that are useful as insect repellents, especially biting flies, chiggers, fleas, mosquitoes, ticks and lice. |
| 06/27/2006 | US7067677 Hydrogenation catalysts having catalysts selectivity; plant extracts |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/22/2006 | WO2006065686A2 Spiro derivatives as lipoxygenase inhibitors |
| 06/22/2006 | WO2006065561A2 A composition, method of authenticating, methods of making authenticatable compositions, authenticatable articles made there from |
| 06/22/2006 | WO2006064150A1 Method for obtaining stabilised natural polyphenols, polyphenols thus obtained, and use of said polyphenols in the metabolism of glucids |
| 06/22/2006 | WO2006012643A3 Agents with selective k-opioid receptor affinity |
| 06/22/2006 | US20060135794 Process for recovery of plant sterols from by-product of vegetable oil refining |
| 06/22/2006 | US20060135489 Chemical compounds containing tocopherol and at least one additional pharmaceutical active substrate |
| 06/22/2006 | US20060135445 Breast cancer-resistant protein inhibitor |
| 06/22/2006 | US20060134286 Gallocatechin gallate-containing composition |
| 06/22/2006 | US20060131541 Dihydrocoumarin derivative, liquid crystal composition containing the same, and liquid crystal display device |
| 06/22/2006 | US20060131540 Liquid crystal compound having chroman ring, liquid crystal composition comprising the compound and liquid crystal display device comprising the composition |
| 06/22/2006 | CA2589363A1 Spiro derivatives as lipoxygenase inhibitors |
| 06/21/2006 | EP1671963A1 Endurance improving agent |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1670778A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | EP1670777A1 Use of 8-prenylnaringenin for hormone replacement therapy |
| 06/21/2006 | EP1670485A1 Treatment of diseases associated with the egr-1 enhancer element |
| 06/21/2006 | EP1670484A1 Nitric oxide donating derivatives for the treatment of cardiovascular disorders |
| 06/21/2006 | EP1670456A2 Compounds, compositions and methods |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1260230C Production process of camptothecin |
| 06/21/2006 | CN1260219C Method for raising total flavone content in propolis |
| 06/21/2006 | CN1259822C Snow lotus flavone active ingredient production method by cultivating acaleph snow lotus trichome |
| 06/20/2006 | US7064207 Androgen receptor antagonists |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006061392A2 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 06/15/2006 | WO2005085188A3 Compounds and methods for anti-tumor therapy |
| 06/15/2006 | US20060128764 Non-steroidal farnesoid x receptor modulators and methods for the use thereof |
| 06/15/2006 | US20060128662 Novel compounds for treatment of obesity |
| 06/15/2006 | US20060128033 Fluorogenic dyes |
| 06/15/2006 | US20060127986 Genetically engineered Recombinant actinomycete cells for use as tool for the generation of heterologous proteins; contains nucleic acid molecules which comprise at least two modules that encode a modular polyketide synthase |
| 06/15/2006 | CA2588760A1 Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives |
| 06/15/2006 | CA2587928A1 Phenylpiperazines with a combination of affinity for dopamine -d2 receptors and serotonin reuptake sites |
| 06/14/2006 | EP1669338A1 Process for producing product containing proanthocyanidin in high proportion |
| 06/14/2006 | EP1667999A1 Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| 06/14/2006 | EP1667988A1 Coumarins as inos inhibitors |
| 06/14/2006 | EP1572696B1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones |
| 06/14/2006 | EP1309315B1 Rapidly disintegrating oral formulation of valdecoxib |
| 06/14/2006 | EP1102742B1 Compounds and compositions for delivering active agents |
| 06/14/2006 | EP0804462B2 An aglucone isoflavone enriched vegetable protein isolate and process for producing |
| 06/14/2006 | EP0723536B2 An aglucone isoflavone enriched vegetable protein whey, and process for producing |
| 06/14/2006 | CN1785993A Preparation method of non natural isocumarin and its 3,4-dihydro derivative and use thereof |
| 06/14/2006 | CN1785992A Method of extracting dibydro myricetrin from vine tea |
| 06/14/2006 | CN1785991A Anti inflammatory detoxication luteolin kind new medicine and its preparation method |
| 06/14/2006 | CN1785990A Method of preparing tea polyphenol by resin adsorption method |
| 06/14/2006 | CN1259314C Hydrophilipolymer and flavone combined object and medicinal composition containing said combined object |
| 06/13/2006 | US7060470 Isoflavone-β-D-glucan produced by Agaricus blazei in the submerged liquid culture and method of producing same |
| 06/08/2006 | WO2006058778A2 Luminescent indicator dye and optical sensor |
| 06/08/2006 | WO2006032232A3 Novel lysolipin biosynthesis gene cluster |
| 06/08/2006 | WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 06/08/2006 | US20060122061 Arylphenyl-substituted cyclic ketoenols |
| 06/08/2006 | US20060121134 mixing catnip oil dissolved in at least one water immiscible, non-halogenated organic solvent with at least one inorganic base dissolved in water to form a biphasic mixture, stirring the biphasic mixture to hydrolyze ZE-nepetalactone to form ZE-nepetalic acid |
| 06/08/2006 | DE19781792B4 6,7-Disubstituierte 8-Methyl-4-oxo-4H-1-benzopyran-5-carbonsäuren, Fermentationsverfahren zu deren Herstellung und diese Verbindungen enthaltende therapeutische Zusammensetzung 6,7-Disubstituted-8-methyl-4-oxo-4H-1-benzopyran-5-carboxylic acids, to their preparation and therapeutic composition containing compounds fermentation process |
| 06/08/2006 | DE102004055932A1 Zubereitung enthaltend oxidierte Flavonoid-Derivate Preparation containing oxidized flavonoid derivatives |
| 06/07/2006 | EP1666970A1 Compound for resist and radiation-sensitive composition |
| 06/07/2006 | EP1666476A1 A process for purification of proanthocyanidin oligomers |
| 06/07/2006 | EP1666036A1 Hair restorer |
| 06/07/2006 | EP1664078A1 Process for the recovery of a phytolipid composition |
| 06/07/2006 | EP1664067A2 A NEW ROUTE TO alpha-TOCOPHEROL, alpha-TOCOPHERYL ALKANOATES AND PRECURSORS THEREOF |
| 06/07/2006 | EP1664012A1 Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics |
| 06/07/2006 | EP1663937A2 Synthesis of alpha-tocopheryl alkanoates and precursors thereof |
| 06/07/2006 | EP1663931A1 Benzotropolone derivatives and modulation of inflammatory response |
| 06/07/2006 | EP1572674B1 A process for the preparation of (-)-epicatechin from a new natural source namely dichrostachys cinerea |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | CN1781923A Method for preparing 9-nitro-20(s)-camptothecine |
| 06/07/2006 | CN1781922A Camptothecine derivative, preparing method and use |
| 06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
| 06/06/2006 | US7057048 Androgen receptor antagonists |
| 06/06/2006 | US7057040 Substituted aryl alkenoic acid heterocyclic amides |
| 06/06/2006 | US7056952 Isoflavone metabolites |
| 06/06/2006 | US7056921 Substituted chroman derivatives |
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/06/2006 | CA2327723C Bicyclic hydroxamic acid derivatives |
| 06/06/2006 | CA2273789C Process to prepare tolterodine |
| 06/01/2006 | WO2006057323A1 Composition for amyloid-associated disease diagnosis |
| 06/01/2006 | WO2006056850A2 Chroman compounds |
| 06/01/2006 | WO2006056308A2 Flavonoid complexes with cyclodextrins |
| 06/01/2006 | WO2006056297A2 Flavonoid complexes comprising cyclodextrines |
| 06/01/2006 | US20060116421 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; antiinflammatory agent; antiallergen; autoimmune diseases; allergic rhinitis, dermatitis, conjunctivitis, asthma, rheumatoid arthritis and atherosclerosis |
| 06/01/2006 | US20060116418 Materials and methods for treating hypercholesterolemia |
| 06/01/2006 | US20060116364 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer |
| 06/01/2006 | CA2587860A1 Chroman compounds |
| 05/31/2006 | EP1660473A2 Xanthones, thioxanthones and acridinones as dna-pk inhibitors |
| 05/31/2006 | EP1660074A1 7-carboxymethyloxy-3 , 4 , 5-trimethoxy flavone monohyd rate, the preparation method and uses thereof |
| 05/31/2006 | EP1328282B1 Efficient method for producing compositions enriched in anthocyanins |
| 05/31/2006 | CN1780828A Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives |